Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Selective 5-HT1D receptor agonists from MS&D useful for migraine

Dec. 18, 1998

Chirocaine receives first regulatory approval in Sweden

Dec. 18, 1998

Lilly patents novel mGluR modulators

Dec. 18, 1998

Patent claims relating to use of Avant's TP-20 in stroke allowed

Dec. 17, 1998

Another market launch for Orion's COMT inhibitor

Dec. 17, 1998

Zeneca's new pain-relieving agents revealed in patent literature

Dec. 17, 1998

Studies using 5-ht6 antagonist Ro-04-6790 provide new clues about receptor function

Dec. 17, 1998

NPS Pharmaceuticals updates epilepsy program

Dec. 17, 1998

Novel glutamate receptor antagonist shows excellent potential as antiepileptic agent

Dec. 15, 1998

Merckle launches new treatment for narcolepsy in Germany

Dec. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...